microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis (original) (raw)
Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B et al. Colorectal cancer. Lancet 2010; 375: 1030–1047. ArticlePubMed Google Scholar
Pritchard CC, Grady WM . Colorectal cancer molecular biology moves into clinical practice. Gut 2011; 60: 116–129. ArticleCASPubMed Google Scholar
Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D . Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009; 9: 489–499. ArticleCASPubMed Google Scholar
Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu K et al. MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 2011; 32: 247–253. ArticleCASPubMed Google Scholar
Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297. ArticleCASPubMed Google Scholar
Nugent M, Miller N, Kerin MJ . MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. Eur J Surg Oncol 2011; 37: 649–654. ArticleCASPubMed Google Scholar
Wu CW, Ng SS, Dong YJ, Ng SC, Leung WW, Lee CW et al. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 2012; 61: 739–745. ArticleCASPubMed Google Scholar
Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58: 1375–1381. ArticleCASPubMed Google Scholar
Akao Y, Nakagawa Y, Naoe T . let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006; 29: 903–906. ArticleCASPubMed Google Scholar
Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009; 28: 1385–1392. ArticleCASPubMed Google Scholar
Tazawa H, Tsuchiya N, Izumiya M, Nakagama H . Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007; 104: 15472–15477. ArticleCASPubMedPubMed Central Google Scholar
Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR et al. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 2010; 70: 6609–6618. ArticleCASPubMedPubMed Central Google Scholar
Wang P, Zou F, Zhang X, Li H, Dulak A, Tomko RJ et al. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 2009; 69: 8157–8165. ArticleCASPubMedPubMed Central Google Scholar
Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 2008; 68: 3566–3572. ArticleCASPubMed Google Scholar
Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, Kolokythas A et al. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J 2010; 432: 199–205. ArticleCASPubMed Google Scholar
Reddy SD, Ohshiro K, Rayala SK, Kumar R . MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 2008; 68: 8195–8200. ArticleCASPubMedPubMed Central Google Scholar
Begon DY, Delacroix L, Vernimmen D, Jackers P, Winkler R . Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. J Biol Chem 2005; 280: 24428–24434. ArticleCASPubMed Google Scholar
Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, Roberts A et al. Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol 2005; 27: 131–141. CASPubMed Google Scholar
Baritaki S, Sifakis S, Huerta-Yepez S, Neonakis IK, Soufla G, Bonavida B et al. Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection. Int J Oncol 2007; 31: 69–79. CASPubMed Google Scholar
May M, Dong XP, Beyer-Finkler E, Stubenrauch F, Fuchs PG, Pfister H . The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J 1994; 13: 1460–1466. ArticleCASPubMedPubMed Central Google Scholar
Dong XP, Stubenrauch F, Beyer-Finkler E, Pfister H . Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer 1994; 58: 803–808. ArticleCASPubMed Google Scholar
Evan GI, Vousden KH . Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342–348. ArticleCASPubMed Google Scholar
Pan H, Yin C, Dyson NJ, Harlow E, Yamasaki L, Van Dyke T . Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell 1998; 2: 283–292. ArticleCASPubMed Google Scholar
Wieler S, Gagne JP, Vaziri H, Poirier GG, Benchimol S . Poly(ADP-ribose) polymerase-1 is a positive regulator of the p53-mediated G1 arrest response following ionizing radiation. J Biol Chem 2003; 278: 18914–18921. ArticleCASPubMed Google Scholar
Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 1999; 13: 607–619. ArticleCASPubMedPubMed Central Google Scholar
Leu JI, Dumont P, Hafey M, Murphy ME, George DL . Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 2004; 6: 443–450. ArticleCASPubMed Google Scholar
Kimura Y, Furuhata T, Urano T, Hirata K, Nakamura Y, Tokino T . Genomic structure and chromosomal localization of GML (GPI-anchored molecule-like protein), a gene induced by p53. Genomics 1997; 41: 477–480. ArticleCASPubMed Google Scholar
Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR . p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 2000; 275: 7337–7342. ArticleCASPubMed Google Scholar
Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P et al. Yin Yang 1 is a negative regulator of p53. Cell 2004; 117: 859–872. ArticleCASPubMed Google Scholar
Gronroos E, Terentiev AA, Punga T, Ericsson J . YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci USA 2004; 101: 12165–12170. ArticlePubMedPubMed Central Google Scholar
Thorne CA, Hanson AJ, Schneider J, Tahinci E, Orton D, Cselenyi CS et al. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1alpha. Nat Chem Biol 2010; 6: 829–836. ArticleCASPubMedPubMed Central Google Scholar
Tago K, Nakamura T, Nishita M, Hyodo J, Nagai S, Murata Y et al. Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev 2000; 14: 1741–1749. CASPubMedPubMed Central Google Scholar
Bodine PV, Zhao W, Kharode YP, Bex FJ, Lambert AJ, Goad MB et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 2004; 18: 1222–1237. ArticleCASPubMed Google Scholar
Yokoyama NN, Pate KT, Sprowl S, Waterman ML . A role for YY1 in repression of dominant negative LEF-1 expression in colon cancer. Nucleic Acids Res 2010; 38: 6375–6388. ArticleCASPubMedPubMed Central Google Scholar
Ambrosini G, Adida C, Altieri DC . A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917–921. ArticleCASPubMed Google Scholar
Buckland RA, Collinson JM, Graham E, Davidson DR, Hill RE . Antagonistic effects of FGF4 on BMP induction of apoptosis and chondrogenesis in the chick limb bud. Mech Dev 1998; 71: 143–150. ArticleCASPubMed Google Scholar
Balciunaite G, Keller MP, Balciunaite E, Piali L, Zuklys S, Mathieu YD et al. Wnt glycoproteins regulate the expression of FoxN1, the gene defective in nude mice. Nat Immunol 2002; 3: 1102–1108. ArticleCASPubMed Google Scholar
Su DM, Navarre S, Oh WJ, Condie BG, Manley NR . A domain of Foxn1 required for crosstalk-dependent thymic epithelial cell differentiation. Nat Immunol 2003; 4: 1128–1135. ArticleCASPubMed Google Scholar